Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
To analyse the impact on cycle outcome of LH supplementation in ovarian stimulation
controlled with a GnRH antagonist in two ages groups: patients upto 35 years old, and
patients aged between 36 and 39 years old.
Phase:
Phase 3
Details
Lead Sponsor:
Instituto Valenciano de Infertilidad, IVI VALENCIA